Morag Peberdy

Morag Peberdy has specialized in life sciences work for more than twenty years. She advises biotech and pharmaceutical companies, ranging from start-ups through to big pharma, on drafting and negotiating intellectual property-related agreements. She has particular expertise in foundational IP licenses and strategic drug discovery collaborations.

In her work with innovative multi-national, national, and start-up life sciences companies, Morag regularly:

• provides strategic advice on licensing and partnering
• assists clients to put in place R&D and collaboration agreements, patent licenses, intellectual property pipeline arrangements, joint ventures, option agreements, strategic alliances, and other commercial and IP-related contracts; and
• advises on intellectual property issues arising in corporate transactions, including mergers and acquisitions, initial public offerings, venture capital investments, royalty monetizations and restructurings

Morag had a background in biological sciences prior to qualifying as a lawyer and sits on the PLC Life Sciences Consultation Board and the Intellectual Property Advisory Committee of the Bio Industry Association, advising across the spectrum of intellectual property issues impacting life science companies.

Morag’s insight into both contentious and non-contentious IP matters enables her to bring a valuable perspective and breadth of knowledge to strategic intellectual property issues, which is invaluable in assisting clients’ business objectives.

• Member of the UK Bio Industry Association Intellectual Property Advisory Committee for over a decade
• Member of the Consultation Board, PLC Life Sciences Service

Prior to joining Goodwin, Ms Peberdy was most recently Of Counsel at Covington & Burling LLP.

Recognized for excellence in the 2024 edition of The Best Lawyers in the United Kingdom

Featured in “IAM Patent 1000 - The World’s Leading Patent Practitioners”

Expert Guides, Patents and Women in Business Law